Current and future therapeutical approaches for COVID-19

被引:15
|
作者
Duan, Yongtao [1 ]
Yao, Yongfang [2 ]
Kumar, Senthil Arun [3 ]
Zhu, Hai-Liang [1 ,4 ]
Chang, Junbiao [2 ]
机构
[1] Zhengzhou Univ, Henan Prov Key Lab Childrens Genet & Metab Dis, Childrens Hosp, Zhengzhou 450001, Peoples R China
[2] Zhengzhou Univ, Sch Pharmaceut Sci, Zhengzhou 450001, Henan, Peoples R China
[3] Zhengzhou Univ, Dept Endocrinol & Metab, Genet, Childrens Hosp, Zhengzhou 450001, Peoples R China
[4] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China
基金
中国国家自然科学基金;
关键词
DRUG DISCOVERY; SARS; PNEUMONIA; PLASMA; ARBIDOL;
D O I
10.1016/j.drudis.2020.06.018
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Coronavirus 2019 (COVID-19), the WHO-classified novel coronavirus of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly become a global pandemic. To tackle both its spread and virulence, research is ongoing worldwide to develop an effective anti-COVID-19 drug or vaccine. In this review, we explore the clinical understanding and severity of COVID-19 emergence across the world, with a focus on China. We also discuss potential therapeutic targets, either host virus based, that could be used to tackle the COVID-19 outbreak.
引用
收藏
页码:1545 / 1552
页数:8
相关论文
共 50 条
  • [31] Current knowledge of COVID-19: Advances, challenges and future perspectives
    Yuhan Wu
    Zhuobing Peng
    Yongxue Yan
    Jintao Hu
    Yalong Wang
    Xiaoyu Wang
    Ruchao Peng
    Daniel Watterson
    Yi Shi
    生物安全与健康(英文), 2021, 03 (04) : 202 - 209
  • [32] COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies
    Salian, Vrishali S.
    Wright, Jessica A.
    Vedell, Peter T.
    Nair, Sanjana
    Li, Chenxu
    Kandimalla, Mahathi
    Tang, Xiaojia
    Porquera, Eva M. Carmona
    Kalari, Krishna R.
    Kandimalla, Karunya K.
    MOLECULAR PHARMACEUTICS, 2021, 18 (03) : 754 - 771
  • [33] Microfluidics for COVID-19: From Current Work to Future Perspective
    Li, Qi
    Zhou, Xingchen
    Wang, Qian
    Liu, Wenfang
    Chen, Chuanpin
    BIOSENSORS-BASEL, 2023, 13 (02):
  • [34] COVID-19 and Gastrointestinal Disease: Current Insights and Future Management
    Kopel, Jonathan
    Goyal, Hemant
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (07)
  • [35] Current community transmission and future perspectives on the COVID-19 process
    Turk, Seyhan
    Turk, Can
    Malkan, Umit Yavuz
    Temirci, Elif Sena
    Peker, Mustafa Cagri
    Haznedaroglu, Ibrahim Celalettin
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (03) : 1001 - 1011
  • [36] Current knowledge of COVID-19: Advances, challenges and future perspectives
    Wu, Yuhan
    Peng, Zhuobing
    Yan, Yongxue
    Hu, Jintao
    Wang, Yalong
    Wang, Xiaoyu
    Peng, Ruchao
    Watterson, Daniel
    Shi, Yi
    BIOSAFETY AND HEALTH, 2021, 3 (04) : 202 - 209
  • [37] Heparin as a therapy for COVID-19: current evidence and future possibilities
    Hippensteel, Joseph A.
    LaRiviere, Wells B.
    Colbert, James F.
    Langouet-Astrie, Christophe J.
    Schmidt, Eric P.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2020, 319 (02) : L211 - L217
  • [38] COVID-19: Current and future crisis planning in breast imaging
    Gerlach, Karen
    Phalak, Kanchan
    Patel, Miral
    Leung, Jessica W. T.
    BREAST JOURNAL, 2020, 26 (08): : 1615 - 1617
  • [39] COVID-19 and Clinical Trials: Current Challenges and Future Directions
    Singh, Vinay
    Garg, Sandeep
    Klimek, Monika
    Sinha, Rajeev Ranjan
    Dhanwal, Dinesh
    REVIEWS ON RECENT CLINICAL TRIALS, 2021, 16 (03) : 258 - 261
  • [40] Editorial: COVID-19 and diabetes: Current findings and future perspectives
    Prabhakar, Pranav Kumar
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15